DYNAVAX TECHNOLOGIES CORP's ticker is DVAX and the CUSIP is 268158201. A total of 207 filers reported holding DYNAVAX TECHNOLOGIES CORP in Q1 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $362 | +21.9% | 24,484 | +6.6% | 0.03% | +21.7% |
Q2 2023 | $297 | -1.3% | 22,959 | -25.3% | 0.02% | +4.5% |
Q1 2023 | $301 | -16.6% | 30,717 | -9.4% | 0.02% | -26.7% |
Q4 2022 | $361 | -99.9% | 33,893 | -17.1% | 0.03% | -25.0% |
Q3 2022 | $427,000 | +11.8% | 40,888 | +34.9% | 0.04% | +14.3% |
Q2 2022 | $382,000 | +28.2% | 30,319 | +10.2% | 0.04% | +250.0% |
Q1 2022 | $298,000 | +63.7% | 27,513 | +112.5% | 0.01% | +66.7% |
Q4 2021 | $182,000 | +28.2% | 12,946 | -10.6% | 0.01% | -50.0% |
Q1 2021 | $142,000 | – | 14,474 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Chicago Capital, LLC | 5,791,735 | $85,543,929 | 4.00% |
Deep Track Capital, LP | 6,756,956 | $99,800,240 | 3.85% |
Intrinsic Edge Capital Management LLC | 1,133,099 | $16,735,872 | 1.89% |
Bain Capital Life Sciences Investors, LLC | 915,000 | $13,514,550 | 1.51% |
Kynam Capital Management, LP | 500,000 | $7,385,000 | 1.21% |
Rhenman & Partners Asset Management AB | 700,000 | $10,339,000 | 1.12% |
AlphaCentric Advisors LLC | 110,000 | $1,624,700 | 0.92% |
HighVista Strategies LLC | 133,000 | $1,964,410 | 0.91% |
Affinity Asset Advisors, LLC | 200,000 | $2,954,000 | 0.83% |
Rock Springs Capital Management LP | 1,813,758 | $26,789,206 | 0.72% |